Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179627 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Caroline A Snyder und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biology, Engineering and Medicine, School of Engineering, Brown University, Providence, RI 02912, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Cardiac, Cell Hypoxia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Brown University 2023 OVPR Seed Award, National Institute of Health.
Abstract (Originalsprache)
Acute myocardial infarction (MI) is a sudden, severe cardiac ischemic event that results in the death of up to one billion cardiomyocytes (CMs) and subsequent decrease in cardiac function. Engineered cardiac tissues (ECTs) are a promising approach to deliver the necessary mass of CMs to remuscularize the heart. However, the hypoxic environment of the heart post-MI presents a critical challenge for CM engraftment. Here, we present a high-throughput, systematic study targeting several physiological features of human induced pluripotent stem cell-derived CMs (hiPSC-CMs), including metabolism, Wnt signaling, substrate, heat shock, apoptosis, and mitochondrial stabilization, to assess their efficacy in promoting ischemia resistance in hiPSC-CMs. The results of 2D experiments identify hypoxia preconditioning (HPC) and metabolic conditioning as having a significant influence on hiPSC-CM function in normoxia and hypoxia. Within 3D engineered cardiac tissues (ECTs), metabolic conditioning with maturation media (MM), featuring high fatty acid and calcium concentration, results in a 1.5-fold increase in active stress generation as compared to RPMI/B27 control ECTs in normoxic conditions. Yet, this functional improvement is lost after hypoxia treatment. Interestingly, HPC can partially rescue the function of MM-treated ECTs after hypoxia. Our systematic and iterative approach provides a strong foundation for assessing and leveraging in vitro culture conditions to enhance the hypoxia resistance, and thus the successful clinical translation, of hiPSC-CMs in cardiac regenerative therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Biology, Engineering and Medicine, School of Engineering, Brown University, Providence, RI 02912, USA.
ORCID-Profile: Caroline A Snyder, Kiera D Dwyer, Kareen L K Coulombe
Förderung
- NHLBI NIH HHS
- Brown University 2023 OVPR Seed Award
- National Institute of Health
- Brown University School of Engineering Carl Nielsen ‘56 Fellowship and Royce Fellowship
- NSF-GRFP
Zitieren
APA
Snyder, C. A., Dwyer, K. D., & Coulombe, K. L. K. (2024). Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179627
Vancouver
Snyder CA, Dwyer KD, Coulombe KLK. Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179627
BibTeX
@article{Snyder2024,
author = {Snyder, Caroline A and Dwyer, Kiera D and Coulombe, Kareen L K},
title = {Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179627}
}
EUVIMED